Jan. 31st, 2008
Mutant Flu Virus Is Found That Resists Popular Drug
Dec. 31st, 2007
Nature Biotechnology Feature Article "Antivirals Become a Broader
Enterprise" Ends by Highlighting Fludase (DAS181) Novelty
Dec. 15th, 2007
Reuters Health Reports for the Second Time the CDC/NexBio Publication
on Fludase (DAS181) against the H5N1 Bird Flu Virus
Nov 15th, 2007
Scientists at the CDC and NexBio Show Fludase (DAS181) Effectively
Protects Animals from Lethal H5N1 Bird Flu Viral Infection
Oct. 31, 2007
NexBio to Present at 2007 BIOCOM Investor Conference
April 28th, 2007
NexBio CEO, Dr. Mang Yu, is Named as a Semifinalist of the 21st San
Diego "Entrepreneur of the Year" 2007
March 22nd, 2007
Time Magazine: Danger from the Current Leading Flu Drug?
Feb. 5th, 2007
Science Article Highlights Receptor Binding is Critical for the Past and the
Up-Coming Influenza Pandemic
Feb. 1st, 2007
Fludase Current Description, as Profiled by Drug Development
Technology
Jan. 18th, 2007
The New York Times: New strain of bird flu found in Egypt is resistant to
antiviral drug
Nov. 14th, 2006
NPR News: FDA Orders Caution Regarding Tamiflu
Oct. 31st, 2006
The Ever-changing Potential Pandemic Flu Virus Challenges the Current
Effort and Design of H5N1 Vaccines Again
Oct. 1st, 2006
Cambrex Completes cGMP Manufacture Of NexBio’s Fludase® (DAS181)
Aug. 24th, 2006
A Truly Broad-Spectrum Influenza Medicine Other Than an H5N1 Vaccine
is Needed to Combat the Up-Coming Influenza Pandemic
Aug. 15th, 2006
Fish & Richardson Wins in Court for NexBio
June 5th, 2006
NexBio CEO Invited by the NIH as a Panelist for its Interactive Workshop
with the FDA on the Development of Broad Spectrum Therapeutics
May 13th, 2006
Voice of America TV /Radio Health Forum Featuring NexBio CEO on Bird
Flu (watch the 40 min. Interview and Q&A with Viewers & Listeners)
May 1st, 2006
Reuters Health Reports NexBio's Scientific Publication on Fludase
(DAS181) as a Novel Broad-Spectrum Inhibitor of Influenza Viral Infection
May 1st, 2006
Sialidase Fusion Protein as Novel Broad-Spectrum Inhibitor of Influenza
Virus Infection
March 1st, 2006
Newsweek Lists Fludase from NexBio on the Top of the List of Promising
Influenza Medicines
Feb. 28th, 2006,
NexBio CEO Named as a Board Member of Bridgetech Holding
International, a Publicly Traded Multi-National Healthcare Company
Feb. 17th, 2006
Australia-based Lowy Institute Think Tank Study: Influenza Pandemic
Could Take 142 Million Lives and $4.4 Trillion in Worst-Case Scenario
Feb. 1st, 2006
NexBio CEO Tells NBC 7/39 TV Viewers: "The latest news on the Iraqi
human case of bird flu is disturbing, but there is no reason to panic"
Jan. 27th, 2006
NexBio CEO Addresses Industrial Leaders as a Panelist for the Influenza
Pandemic at the "3rd Annual Anti Infectives Partnering & Deal-Making
Summit"
Jan. 25th, 2006
NexBio and Fludase Featured in the "QUEST" Section of the San Diego
Union-Tribune as a Future Weapon for Pandemic Flu
Nov. 8th, 2005
MS NBC Featuring Fludase in "New Ammunition against Bird Flu in the
Works"
Nov. 8th, 2005
NexBio Awarded “SCIENTIFIC AMERICAN 50” For Its Quest For the
Ultimate Influenza Medicine
Nov. 1st, 2005
Channel 10/ABC NEWS Broadcasts a Live Interview with NexBio's CSO
/CMO in Response to President Bush's $7.1 B Flu Plan
Oct. 31st, 2005
Fortune Magazine Interviews NexBio CEO & CSO /CMO for Their Expert
Opinions
Oct. 24th, 2005
Scientific American Features Fludase & NexBio in "Preparing for a
Pandemic: New Flu Drugs".
Aug. 16th, 2005
BioCentury, the Bernstein Report on BioBusiness, Covers NexBio &
Fludase (PDF)
Aug. 8th, 2005
NexBio's First News Release: NexBio Awarded a $6 Million NIH SBIR
Grant for the Clinical Development of a Novel Influenza Medicine (PDF)
June 1st, 2005
Expert Toxicologist & FDA Veteran Dr. Joy Cavagnaro Becomes a New
Member of NexBio's World Class Advisory Board
May 26th, 2005
Nature News Article Calling for "Quantum Leap" Development for Flu
Medicine and Featuring NexBio & Fludase
April 10th, 2005
Genetic Engineering News Featuring a Full Corporate & Product Profile on
NexBio & Fludase (PDF)
Jan. 28th, 2005
NexBio's Chief Scientific & Medical Officer Featured in the "People to
Watch" in the Life Sciences Industry by San Diego Union Tribune
Jan. 20th, 2005
ABC/Channel 10 NEWS Features NexBio and Fludase (watch the 2.2 min.
TV news here by clicking on this link).
Jan. 15th, 2005
BusinessWeek Magazine Reports on NexBio's Potential Flu Medicine,
Fludase
Dec. 30th, 2004
"Next Generation Flu Fighters" - NexBio Featured by Southern California's
North County Times
Dec. 28th, 2004
Avian Influenza: Catastrophe Waiting in the Wings? - Article in Science
Magazine's "BREAKTHROUGH OF THE YEAR"
Dec. 26th, 2004
NexBio Featured by NIH News Article: New Drugs Against Flu - Blocking
the Entryways
Dec. 25th, 2004
Science & Technology Daily Report on NexBio and its Promising Product
Nov. 26th, 2004
NexBio Coins A New Term of "Biochemical Prevention" in Virology Journal
to Distinguish a New Approach from Traditional Vaccines
Feb. 24th, 2004
NexBio CSO Delivers "Getting Ready for Pandemic Influenza" Speech at
Taiwan-US Biotech Forum and Is Featured by World Journal
May 14th, 2003
NexBio Chairman Featured on Inside Business Radio Show as a
Biopharmaceutical Serial Entrepreneur
News
